Glycogen synthase kinase 3
From Proteopedia
| |||||||||||
3D structures of glycogen synthase kinase 3
Updated on 01-June-2017 {{#tree:id=OrganizedByTopic|openlevels=0|
- GSK-3
- GSK-3 binary complex
- 1gng - hGSK-3 β + Frattide peptide
- 1q4l, 1uv5, 1q5k, 1r0e, 2o5k, 2ow3, 3du8, 3f7z, 3f88, 3i4b, 3gb2, 3l1s, 3q3b, 3zrk, 3zrl, 3zrm, 3sd0, 4dit, 4afj, 4acc, 4acd, 4acg, 4ach, 3say, 4iq6, 4j1r, 4j71, 5k5n, 5hlp, 5hln, [[5f94, 5f95 - hGSK-3 β + inhibitor
- 1pyx, 1j1b - hGSK-3 β + AMPPNP
- 1j1c - hGSK-3 β + ADP
- 1q3d, 1q3w, 1q41 - hGSK-3 β + ATP-mimetic inhibitor
- 4ptc, 4pte, 4ptg - hGSK-3 β + acylaminopyridine inhibitor
- 3m1s, 3pup - hGSK-3 β + Ru complex
- 4nm0, 4nm3, 4nu1, 1o9u, 4b7t - hGSK-3 β + Axin peptide
- 1gng - hGSK-3 β + Frattide peptide
- GSK-3 ternary complex
}}
References
- ↑ Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci. 2007 Aug;64(15):1930-44. PMID:17530463 doi:http://dx.doi.org/10.1007/s00018-007-7045-7
- ↑ Jope RS, Roh MS. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets. 2006 Nov;7(11):1421-34. PMID:17100582
- ↑ Atilla-Gokcumen GE, Di Costanzo L, Meggers E. Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3beta. J Biol Inorg Chem. 2010 Sep 7. PMID:20821241 doi:10.1007/s00775-010-0699-x

